A share price of Charles River Laboratories International Inc [CRL] is currently trading at $138.79, down -1.82%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CRL shares have gain 17.16% over the last week, with a monthly amount drifted -0.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Charles River Laboratories International Inc [NYSE: CRL] stock has seen the most recent analyst activity on May 08, 2025, when Evercore ISI upgraded its rating to a Outperform but kept the price target unchanged to $170 for it. Previously, Goldman downgraded its rating to Neutral on March 21, 2025, and dropped its price target to $170. On March 04, 2025, upgrade upgraded it’s rating to Neutral and revised its price target to $175 on the stock. Redburn Atlantic upgraded its rating to a Neutral but stick to its price target of $188 on March 03, 2025. William Blair downgraded its rating to a Mkt Perform. UBS downgraded its rating to Neutral for this stock on January 17, 2025, and downed its price target to $185. In a note dated November 18, 2024, CLSA downgraded an Underperform rating on this stock but restated the target price of $164.
Charles River Laboratories International Inc experienced fluctuations in its stock price throughout the past year between $91.86 and $254.15. Currently, Wall Street analysts expect the stock to reach $303.6 within the next 12 months. Charles River Laboratories International Inc [NYSE: CRL] shares were valued at $138.79 at the most recent close of the market. An investor can expect a potential return of 118.75% based on the average CRL price forecast.
Analyzing the CRL fundamentals
Trailing Twelve Months sales for Charles River Laboratories International Inc [NYSE:CRL] were 4.02B which represents -2.71% decline. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 137.01 points at the first support level, and at 135.24 for the second support level. However, for the 1st resistance point, the stock is sitting at 142.01, and for the 2nd resistance point, it is at 145.24.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Charles River Laboratories International Inc [NYSE:CRL] is 1.43. Also, the Quick Ratio is 1.16, while the Cash Ratio stands at 0.2. Considering the valuation of this stock, the price to sales ratio is 1.69, the price to book ratio is 2.13.
Transactions by insiders
Recent insider trading involved FOSTER JAMES C, Chairman, President and CEO, that happened on Feb 20 ’25 when 6075.0 shares were purchased. Corporate Executive VP & COO, Girshick Birgit completed a deal on Feb 20 ’25 to buy 1514.0 shares. Meanwhile, EVP, Corp Strategy & Develop LaPlume Joseph W sold 4400.0 shares on Feb 20 ’25.
